Investigational Site Number :7240005

Valencia, Valenciana, Comunidad 46017

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Plasma Cell Myeloma

Studies at this site

• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients — Completed